CLGN
Price
$4.25
Change
-$0.06 (-1.39%)
Updated
Nov 14 closing price
13 days until earnings call
GDTC
Price
$2.12
Change
-$0.10 (-4.50%)
Updated
Nov 14 closing price
12 days until earnings call
Ad is loading...

CLGN vs GDTC

Header iconCLGN vs GDTC Comparison
Open Charts CLGN vs GDTCBanner chart's image
CollPlant Biotechnologies
Price$4.25
Change-$0.06 (-1.39%)
Volume$14.85K
CapitalizationN/A
CytoMed Therapeutics
Price$2.12
Change-$0.10 (-4.50%)
Volume$4.63K
CapitalizationN/A
CLGN vs GDTC Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLGN vs. GDTC commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and GDTC is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (CLGN: $4.25 vs. GDTC: $2.12)
Brand notoriety: CLGN and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 117% vs. GDTC: 31%
Market capitalization -- CLGN: $48.68M vs. GDTC: $24.46M
CLGN [@Biotechnology] is valued at $48.68M. GDTC’s [@Biotechnology] market capitalization is $24.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, GDTC is a better buy in the long-term than CLGN.

Price Growth

CLGN (@Biotechnology) experienced а +12.14% price change this week, while GDTC (@Biotechnology) price change was -16.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

CLGN is expected to report earnings on Apr 02, 2025.

GDTC is expected to report earnings on May 05, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
CLGN($48.7M) has a higher market cap than GDTC($24.5M). CLGN YTD gains are higher at: -33.490 vs. GDTC (-56.735).
CLGNGDTCCLGN / GDTC
Capitalization48.7M24.5M199%
EBITDAN/AN/A-
Gain YTD-33.490-56.73559%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CLGN: Fundamental Ratings
CLGN
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CLGN and

Correlation & Price change

A.I.dvisor tells us that CLGN and CLLS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLGN and CLLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-1.39%
CLLS - CLGN
33%
Poorly correlated
-3.54%
ANNX - CLGN
22%
Poorly correlated
-3.36%
PBYI - CLGN
21%
Poorly correlated
+0.67%
BIXT - CLGN
20%
Poorly correlated
+5.32%
GDTC - CLGN
20%
Poorly correlated
-4.50%
More

GDTC and

Correlation & Price change

A.I.dvisor tells us that GDTC and CVKD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GDTC and CVKD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-4.50%
CVKD - GDTC
31%
Poorly correlated
+0.06%
ADIL - GDTC
30%
Poorly correlated
+15.04%
RXRX - GDTC
25%
Poorly correlated
-5.60%
CLGN - GDTC
24%
Poorly correlated
-1.39%
VALN - GDTC
21%
Poorly correlated
-0.20%
More